Recent rulings in the Caronia and Amarin cases have changed the way off-label marketing regulations and enforcement are viewed. Join us as we discuss the impact of these rulings on the current healthcare landscape.
- What is the scope of the Amarin ruling?
- How to distinguish between “truthful” and “misleading” marketing claims
- What do the rulings mean for companies?
- How to mitigate your company’s risk
Download the presentation:
Off-label marketing regulations and enforcement
*If you are viewing a recording of this web seminar, most state bar organizations will only allow you to claim self-study CLE credit. Please refer to your state's CLE rules. If you have any questions regarding CLE approval of this course in your applicable bar, please contact your bar administrator.